Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
781.00
Change Change %
5.05 0.65%

Updated:21 Sep, 2018, 10:54 AM IST

BSE
782.00
Change Change %
6.30 0.81%

Updated:21 Sep, 2018, 10:49 AM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Religare
N/A
11-02-2016 Buy 671.55 1000.00
N/A
Closed Custom
11-02-2017

Religare maintains buy on Aurobindo Pharma

Aurobindo's topline grew 10.4 per cent year-on-year to Rs 3,490 crore on robust US sales led by ramp-up in recent launches. However, net profit was below expectation due to lower other income. Revise FY17/FY18 revenue estimates by 5.5 and 4.4 per cent respectively building in lower sales and slow European Union business recovery.

Top